Download PDF
Synlett 2023; 34(13): 1621-1625
DOI: 10.1055/a-2099-6309
letter

Visible-Light-Promoted Click [3+2] Cycloaddition of Aziridine with Alkyne: An Efficient Synthesis of Dihydropyrrolidine

Ritu Kapoor∗
a   Ayush and Green Technology Research Lab, Department of Chemistry, University of Allahabad, Prayagraj 211002, India
,
Ruchi Chawla 
b   Polymer Research Laboratory, Department of Chemistry, Motilal Nehru National Institute of Technology Allahabad, Prayagraj, 211004, India
,
Ankit Verma
c   Laboratory of Green Chemistry, Department of Chemistry, University of Allahabad, Prayagraj 211002, India
,
Twinkle Keshari
d   Department of Chemistry, Veer Kunwar Singh University, Arrah, India
,
I. R. Siddiqui∗
c   Laboratory of Green Chemistry, Department of Chemistry, University of Allahabad, Prayagraj 211002, India
› Author AffiliationsR. K. acknowledges the financial support from Department of Science and Technology (DST), Ministry of Science and Technology, India for the award of DST WOS-A project (ref. no. DST/WOS-A/CS-79/2019 (G)). R.C. is thankful to the DST, India for the award of DST WOS-A project (ref. no. SR/WOS-A/CS-54/2018) and financial support.
› Further Information
    Permissions and Reprints All articles of this category


Abstract

A photocatalytic [3+2] cycloaddition of aziridines with activated alkynes is reported under visible-light irradiation in the presence of ruthenium catalyst. This chemical transformation provides polysubstituted pyrrolidines in good yields based on the click chemistry philosophy. The reaction successfully represents a primary trial of cyclocarboamination through photocascade catalysis combining energy transfer and redox neutral reactions.

Key words

aziridine - alkyne - dihydropyrrolidine - visible light - click chemistry - photoredox catalysis


Publication History

Received: 20 February 2023

Accepted after revision: 24 May 2023

Accepted Manuscript online:
24 May 2023

Article published online:
26 June 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References and Notes

    • 1a Smalley RK. In Comprehensive Heterocyclic Chemistry, Vol. 7. Katritzky AR, Rees CW. Pergamon Press; Oxford: 1984: 491-546
      CrossrefGoogle Scholar
    • 1b Leimgruber W, Stefanovic V, Schenker F, Karr A, Berger J. J. Am. Chem. Soc. 1965; 87: 5791
      CrossrefPubMed
    • 1c Zaman L, Arakawa O, Shimosu A, Onoue Y, Nishio S, Shida Y, Noguchi T. Toxicon 1997; 35: 205
      CrossrefPubMed
    • 1d Komoda T, Sugiyama Y, Abe N, Imachi M, Hirota H, Hirota A. Tetrahedron Lett. 2003; 44: 1659
      Crossref
    • 1e Beutler JA, Brubaker AN. Drugs Future 1987; 12: 957
    • 1f Brown DG, Bernstein PR, Wu Y, Urbanek RA, Becker CW, Throner SR, Dembofsky BT, Steelman GB, Lazor LA, Scott CW, Wood MW, Wesolowski SS, Nugiel DA, Koch S, Yu J, Pivonka DE, Li S, Thompson C, Zacco A, Elmore CS, Schroeder P, Liu J.-W, Hurley CA, Ward S, Hunt HJ, Williams K, McLaughlin J, Hoesch V, Sydserff S, Maier D, Aharony D. ACS Med. Chem. Lett. 2013; 4: 46
      CrossrefPubMed

      Selected recent reports on the synthesis of pyrrole and azepine derivatives:
    • 2a Evans PA, Inglesby PA. J. Am. Chem. Soc. 2012; 134: 3635
      CrossrefPubMed
    • 2b Jiang H, He J, Liu T, Yu J.-Q. J. Am. Chem. Soc. 2016; 138: 2055
      CrossrefPubMed
    • 2c Liu R, Winston-Mcpherson GN, Yang Z.-Y, Zhou X, Song W, Guzei IA, Xu X, Tang W. J. Am. Chem. Soc. 2013; 135: 8201
      CrossrefPubMed
    • 2d Shaw MH, Melikhova EY, Kloer DP, Whittingham WG, Bower JF. J. Am. Chem. Soc. 2013; 135: 4992
      CrossrefPubMed
    • 2e Shaw MH, McCreanor NG, Whittingham WG, Bower JF. J. Am. Chem. Soc. 2015; 137: 463
      CrossrefPubMed
    • 2f Nicolle SM, Lewis W, Hayes CJ, Moody C. J. Angew. Chem. Int. Ed. 2016; 55: 3749
      CrossrefPubMed
    • 2g Liu K, Zhu C, Min J, Peng S, Xu G, Sun J. Angew. Chem. Int. Ed. 2015; 54: 12962
      CrossrefPubMed
    • 2h Knight JG, Tchabanenko K, Stoker PA, Harwood SJ. Tetrahedron Lett. 2005; 46: 6261
      Crossref
    • 2i Ohmatsu K, Imagawa N, Ooi T. Nat. Chem. 2014; 6: 47
      CrossrefPubMed

      • Azepines:
    • 2j Yang J.-M, Zhu C.-Z, Tang X.-Y, Shi M. Angew. Chem. Int. Ed. 2014; 53: 5142
      CrossrefPubMed
    • 2k Nakamura I, Okamoto M, Sato Y, Terada M. Angew. Chem. Int. Ed. 2012; 51: 10816
      CrossrefPubMed
    • 2l Zhou M.-B, Song R.-J, Wang C.-Y, Li J.-H. Angew. Chem. Int. Ed. 2013; 52: 10805
      CrossrefPubMed
    • 2m Yang Y, Zhou M.-B, Ouyang X.-H, Pi R, Song R.-J, Li J.-H. Angew. Chem. Int. Ed. 2015; 54: 6595
      CrossrefPubMed
    • 2n Wender PA, Pedersen TM, Scanio MJ. C. J. Am. Chem. Soc. 2002; 124: 15154
      CrossrefPubMed
    • 2o Shi Z, Grohmann C, Glorius F. Angew. Chem. Int. Ed. 2013; 52: 5393
      CrossrefPubMed
    • 2p Li T, Xu F, Li X, Wang C, Wan B. Angew. Chem. Int. Ed. 2016; 55: 2861
      CrossrefPubMed

      • For reviews, see:
    • 2q Nakamura I, Yamamoto Y. Chem. Rev. 2004; 104: 2127
      CrossrefPubMed
    • 2r Han M.-Y, Jia J.-Y, Wang W. Tetrahedron Lett. 2014; 55: 784
      Crossref
  • 3 Feng J-J, Zhang J. ACS Catal. 2016; 6: 6651
    CrossrefPubMed
  • 4 Kinderman SS, van Maarseveen JH, Schoemaker HE, Hiemstra H, Rutjes FP. J. T. Org. Lett. 2001; 3: 2045
    CrossrefPubMed
  • 5 Feldman KS, Bruendl MM, Schildknegt K, Bohnstedt AC. J. Org. Chem. 1996; 61: 5440
    Crossref
    • 7a Wolf LB, Tjen KC. M. F, Rutjes FP. J. T, Hiemstra H, Schoemaker HE. Tetrahedron Lett. 1998; 39: 5081
      Crossref
    • 7b Busacca CA, Dong Y. Tetrahedron Lett. 1996; 37: 3947
      Crossref
    • 7c Yin Y, Ma W, Chai Z, Zhao G. J. Org. Chem. 2007; 72: 5731
      CrossrefPubMed
    • 7d Ma S, Yu F, Li J, Gao W. Chem. Eur. J. 2007; 13: 247
      CrossrefPubMed
  • 8 Zhou X, Zhang H, Yuan J, Mai L, Li Y. Tetrahedron Lett. 2007; 48: 7236
    CrossrefPubMed
    • 9a Ding C.-H, Dai L.-X, Hou X.-L. Tetrahedron 2005; 61: 9586
      Crossref
    • 9b Knight DW, Redfern AL, Gilmore J. J. Chem. Soc., Perkin Trans. 1 2002; 622
      Crossref
  • 10 Sonesson C, Hallberg A. Tetrahedron Lett. 1995; 36: 4505
    CrossrefPubMed
    • 11a Saegusa T, Ito Y, Kinoshita H, Tomita S. J. Org. Chem. 1971; 36: 3316
      Crossref
    • 11b Schöllkopf U, Hantke K. Liebigs Ann. Chem. 1973; 1571
      Crossref
    • 11c Guo C, Xue M.-X, Zhu M.-K, Gong L.-Z. Angew. Chem. Int. Ed. 2008; 47: 3414
      CrossrefPubMed
  • 12 Wurz RP, Charette AB. Org. Lett. 2005; 7: 2313
    CrossrefPubMed
  • 13 Strand D, Wender PA. J. Am. Chem. Soc. 2009; 131: 7528
    CrossrefPubMed
  • 14 Sun H, Yang C, Lin R, Xia W. Adv. Synth. Catal. 2014; 356: 2775
    Crossref
    • 15a Kapoor R, Tripathi S, Singh SN, Keshari T, Yadav LD. S. Tetrahedron Lett. 2017; 58: 3814
      Crossref
    • 15b Kapoor R, Chawla R, Yadav LD. S. Tetrahedron Lett. 2019; 60: 805
      CrossrefPubMed
    • 15c Chawla R, Yadav LD. S. Org. Biomol. Chem. 2019; 17: 4761
      CrossrefPubMed
    • 15d Kapoor R, Chawla R, Yadav LD. S. Tetrahedron Lett. 2020; 61: 152505
      Crossref
  • 16 Ye Q, Xu X, Cheng D, Guan B, Ye H, Li X. ARKIVOC 2017; (v): 314
    CrossrefPubMed
  • 17 Fukuyama T, Jow C.-K, Cheung M. Tetrahedron Lett. 1995; 36: 6373
    CrossrefPubMed
  • 18 General Procedure for the Synthesis of 2,3-Dihydropyrroles 3 To a stirred solution of aziridine (1 mmol) and alkyne (2 mmol) in isopropyl alcohol (3 mL) was added PhN2BF4 (1.5 equiv) and Ru(bpy)3(BF4)2 photocatalyst (2 mol%) at room temperature under visible-light irradiation (blue LED, 3 W, λ = 427 nm). The reaction typically turned yellow or orange/brownish as the reaction progressed. Upon complete consumption of aziridine (TLC control), the reaction was added onto a short SiO2 flash column (flushed with Et3N (5%) doped eluent) or an Al2O3 (neutral) flash column and eluted with 6.25% ethyl acetate in petroleum ether. Product-containing fractions were concentrated under reduced pressure to leave the corresponding dihydropyrroles 3. Characterization Data of Representative Compounds 3 3,5-Diphenyl-1-tosyl-2,3-dihydro-1H-pyrrole (3a) 1H NMR (400 MHz, CDCl3): δ = 7.70–7.65 (m, 2 H), 7.60–7.50 (m, 2 H), 7.49–7.44 (m, 3 H), 7.26–7.21 (m, 2 H), 7.19–7.14 (m, 3 H), 6.79–6.74 (m, 2 H), 5.32 (d, J = 2.4 Hz, 1 H), 4.40 (dd, J = 11.9, 8.7 Hz, 1 H), 3.83 (dd, J = 11.9, 9.4 Hz, 1 H), 3.61 (ddd, J = 10.0, 8.0, 2.3 Hz, 1 H), 2.45 (s, 3 H).13C NMR (100 MHz, CDCl3): δ = 144.9, 142.9, 141.4, 133.4, 132.6, 129.6, 128.9, 128.5, 128.01, 128.0, 127.6, 127.1, 125.9, 120.0, 59.6, 46.9, 21.9. HRMS (ESI): m/z calcd for [C23H21NO2S + Na+]: 398.1191; found: 398.1196. 3-(4-Bromophenyl)-5-phenyl-1-tosyl-2,3-dihydro-1H-pyrrole (3f) 1H NMR (400 MHz, CDCl3): δ = 7.69–7.66 (m, 2 H), 7.42–7.30 (m, 5 H), 7.29–7.21 (m, 2 H), 7.29–7.20 (m, 2 H), 6.76–6.65 (m, 2 H), 5.39 (d, J = 2.8 Hz, 1 H), 4.28 (dd, J = 12.6, 9.9 Hz, 1 H), 3.82 (dd, J = 12.6, 7.3 Hz, 1 H), 3.69 (ddd, J = 9.9, 7.2, 2.7 Hz, 1 H), 2.32 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 146.4, 144.0, 142.6, 133.9, 132.6, 131.9, 129.2, 130.1, 129.0, 128.6, 128.0, 127.3, 120.9, 118.1, 59.9, 45.2, 21.6. HRMS (ESI): m/z calcd for [C23H20NO2SBr + Na+]: 476.0296; found: 476.0290. 3-Methyl-3,5-diphenyl-1-tosyl-2,3-dihydro-1H-pyrrole (3k) 1H NMR (400 MHz, CDCl3): δ = 7.63–7.56 (m, 2 H), 7.42–7.35 (m, 3 H), 7.33–7.28 (m, 2 H), 7.16–7.08 (m, 3 H), 7.04 (dd, J = 8.0, 0.5 Hz, 2 H), 6.98–6.92 (m, 2 H), 5.40 (s, 1 H), 4.16 (d, J = 12.3 Hz, 1 H), 4.05 (d, J = 12.2 Hz, 1 H), 2.34 (s, 3 H), 2.24 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 147.6, 143.7, 143.5, 133.2, 132.7, 129.2, 128.8, 128.4, 128.3, 127.8, 127.7, 125.9, 125.5, 123.7, 65.6, 48.2, 29.0, 21.5. HRMS (ESI): m/z calcd for [C24H23NO2S + Na+]: 412.1347; found: 412.1345.